B Cell Deficient Mice Are Protected from Biliary Obstruction in the Rotavirus-Induced Mouse Model of Biliary Atresia

Lymphotoxin α1β2expression on B cells is required for follicular dendritic cell activation during the germinal center response

(2012) Riley C. Myers et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells

(2011) Stephen M. Brindley et al.   HEPATOLOGY

B Cell Depletion Enhances T Regulatory Cell Activity Essential in the Suppression of Arthritis

(2011) K. M. Hamel et al.   JOURNAL OF IMMUNOLOGY

Dendritic Cells Regulate Natural Killer Cell Activation and Epithelial Injury in Experimental Biliary Atresia

(2011) V. Saxena et al.   Science Translational Medicine

α-Enolase Autoantibodies Cross-Reactive to Viral Proteins in a Mouse Model of Biliary Atresia

(2010) Brandy R. Lu et al.   GASTROENTEROLOGY

Identification of a novel autoantigen in inflammatory bowel disease by protein microarray

(2010) Nathalie Vermeulen et al.   INFLAMMATORY BOWEL DISEASES

TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica

(2010) T. A. Barr et al.   JOURNAL OF IMMUNOLOGY

Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia

(2009) Barrett H. Barnes et al.   LIVER INTERNATIONAL

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

(2009) Mark D. Pescovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial

(2008) Amit Bar-Or et al.   ANNALS OF NEUROLOGY

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

(2008) R. Stasi et al.   BLOOD

B cell–directed therapies for autoimmune disease and correlates of disease response and relapse

(2008) Marc C. Levesque et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE